TY - JOUR
T1 - Continuity of cancer care
T2 - The surgical experience of two large cancer hubs in london and milan
AU - Monroy Iglesias, Maria
AU - Tagliabue, Marta
AU - Dickinson, Harvey
AU - Roberts, Graham
AU - De Berardinis, Rita
AU - Russell, Beth
AU - Moss, Charlotte
AU - Irwin, Sophie
AU - Olsburgh, Jonathon
AU - Cocco, Ivana Maria Francesca
AU - Schizas, Alexis M. P.
AU - McCrindle, Sarah
AU - Nath, Rahul
AU - Brunet, Aina
AU - Simo, Ricard
AU - Tornari, Chrysostomos
AU - Srinivasan, Parthi
AU - Prachalias, Andreas
AU - Davies, Andrew
AU - Geh, Jenny
AU - Fraser, Stephanie
AU - Routledge, Tom
AU - Ma, Rujun
AU - Doerge, Ella
AU - Challacombe, Ben
AU - Nair, Raj
AU - Hadjipavlou, Marios
AU - Scarpinata, Rosaria
AU - Sorelli, Paolo
AU - Dolly, Saoirse
AU - Mistretta, Francesco Alessandro
AU - Musi, Gennaro
AU - Casiraghi, Monica
AU - Aloisi, Alessia
AU - Dell’acqua, Andrea
AU - Scaglione, Donatella
AU - Zanoni, Stefania
AU - Da Silva, Daniele Rampazio
AU - Brambilla, Daniela
AU - Bertolotti, Raffaella
AU - Peruzzotti, Giulia
AU - Maggioni, Angelo
AU - De Cobelli, Ottavio
AU - Spaggiari, Lorenzo
AU - Ansarin, Mohssen
AU - Mastrilli, Fabrizio
AU - Gandini, Sara
AU - Jain, Urvashi
AU - Hamed, Hisham
AU - Haire, Kate
AU - Van Hemelrijck, Mieke
N1 - Funding Information:
This work was partially supported by the Italian Ministry of Health with Ricerca Corrente and 5 ? 1000 funds.
Funding Information:
Funding: This work was partially supported by the Italian Ministry of Health with Ricerca Corrente and 5 × 1000 funds.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/4/1
Y1 - 2021/4/1
N2 - The SARS-CoV-2 (COVID-19) pandemic is having a large effect on the management of cancer patients. This study reports on the approach and outcomes of cancer patients receiving radical surgery with curative intent between March and September 2020 (in comparison to 2019) in the European Institute of Oncology, IRCCS (IEO) in Milan and the South East London Cancer Alliance (SELCA). Both institutions implemented a COVID-19 minimal pathway where patients were required to self-isolate prior to admission and were swabbed for COVID-19 within 72 h of surgery. Positive patients had surgery deferred until a negative swab. At IEO, radical surgeries declined by 6% as compared to the same period in 2019 (n = 1477 vs. 1560, respectively). Readmissions were required for 3% (n = 41), and <1% (n = 9) developed COVID-19, of which only one had severe disease and died. At SELCA, radical surgeries declined by 34% (n = 1553 vs. 2336). Readmissions were required for 11% (n = 36), <1% (n = 7) developed COVID-19, and none died from it. Whilst a decline in number of surgeries was observed in both centres, the implemented COVID-19 minimal pathways have shown to be safe for cancer patients requiring radical treatment, with limited complications and almost no COVID-19 infections.
AB - The SARS-CoV-2 (COVID-19) pandemic is having a large effect on the management of cancer patients. This study reports on the approach and outcomes of cancer patients receiving radical surgery with curative intent between March and September 2020 (in comparison to 2019) in the European Institute of Oncology, IRCCS (IEO) in Milan and the South East London Cancer Alliance (SELCA). Both institutions implemented a COVID-19 minimal pathway where patients were required to self-isolate prior to admission and were swabbed for COVID-19 within 72 h of surgery. Positive patients had surgery deferred until a negative swab. At IEO, radical surgeries declined by 6% as compared to the same period in 2019 (n = 1477 vs. 1560, respectively). Readmissions were required for 3% (n = 41), and <1% (n = 9) developed COVID-19, of which only one had severe disease and died. At SELCA, radical surgeries declined by 34% (n = 1553 vs. 2336). Readmissions were required for 11% (n = 36), <1% (n = 7) developed COVID-19, and none died from it. Whilst a decline in number of surgeries was observed in both centres, the implemented COVID-19 minimal pathways have shown to be safe for cancer patients requiring radical treatment, with limited complications and almost no COVID-19 infections.
KW - Cancer surgery
KW - COVID-19
KW - Postoperative outcomes
UR - http://www.scopus.com/inward/record.url?scp=85103232119&partnerID=8YFLogxK
U2 - 10.3390/cancers13071597
DO - 10.3390/cancers13071597
M3 - Article
AN - SCOPUS:85103232119
SN - 2072-6694
VL - 13
JO - Cancers
JF - Cancers
IS - 7
M1 - 1597
ER -
